J P M O R G A N (1-212) 622-9074 casey.woodring@jpmchase.com North America Equity Research 21 July 2026 Danaher 2Q26 First Take: Customer Project Timing Drives Bioprocessing Miss This morning, Danaher (DHR) reported (press release/presentation/earnings supplement) a 2Q top and bottom-line beat, driven by solid performance in both LS and Dx but came in below expectations in the Biotechnology segment due to customer project timing that impacted bioprocessing revenue. Looking ahead, DHR narrowed its 2026 non-G ...